Mitomycin
Overview
Mitomycin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL105).
API suppliers (8)
Suppliers of Mitomycin evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 6 of 8 suppliers.
4 of 8 hold a GMP certificate on record in the EU or UK registers
- CONCORD BIOTECH LTDIndia1 active DMF GMP on record
- CHEMWERTH INCFrance1 active DMF
- Wuxi Fortune Pharmaceutical Co., Ltd.China1 active DMF GMP on record
- HUBEI HONCH PHARMACEUTICAL CO LTD1 active DMF
- Zhejiang Hisun Pharmaceutical Co., Ltd.China1 active DMF GMP on record
- TAPI NL BVNetherlands1 active DMF
- KYOWA HAKKO KOGYO CO LTD
- MICROBIOPHARM JAPAN CO LTDJapan GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (22 approved US products), the latest listed US patent on Mitomycin expires 20 Jan 2031 and exclusivity 12 Jun 2028. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- [(4S,6S,7R,8S)-11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate
- Canonical SMILES
- CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)N
- InChIKey
- NWIBSHFKIJFRCO-WUDYKRTCSA-N
Do you supply Mitomycin? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.